Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3578)
All Articles published online
|
Sep 21, 2012 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cieśla A, Bociąga-Jasik M, Sobczyk-Krupiarz I, Głowacki MK, Owczarek D, Cibor D, Sanak M, Mach T. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C. World J Gastroenterol 2012; 18(35): 4892-4897 [PMID: 23002361 DOI: 10.3748/wjg.v18.i35.4892] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i35/4892.htm |
| Number | Citing Articles |
| 1 |
Amira Youssef Shaala, Mona Gamal Morsi, Reem Abdel Hameed Harfoush, Ehab Hassan ElKhouly, Mohamed Abdel Rahman Ahmed, Mohamed Nabil Roshdy. Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis. Alexandria Journal of Medicine 2015; 51(3): 231 doi: 10.1016/j.ajme.2014.09.005
|
| 2 |
Marwa Khairy, Rabab Fouad, Mahassen Mabrouk, Wafaa El-Akel, Abu Bakr Awad, Rabab Salama, Mayada Elnegouly, Olfat Shaker. The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis. Hepatitis Monthly 2013; 13(6) doi: 10.5812/hepatmon.10509
|
| 3 |
Aminata Sy, Leanne McCabe, Emma Hudson, Azim M. Ansari, Vincent Pedergnana, Shang-Kuan Lin, S. Santana, Marzia Fiorino, Aftab Ala, Ben Stone, M. Smith, Mark Nelson, Stephen T. Barclay, Stuart McPherson, Stephen D. Ryder, Jane Collier, Eleanor Barnes, Ann Sarah Walker, Sarah L. Pett, Graham Cooke, Chika Kingsley Onwuamah. Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus. PLOS ONE 2023; 18(1): e0280551 doi: 10.1371/journal.pone.0280551
|
| 4 |
Maryam Karkhane, Abdolrazagh Marzban, Hamed Esmaeil Lashgarian, Mohammad Reza Zali. Genetic Variations in Host Factors and their Critical Role on HCV Medication. Research in Molecular Medicine 2017; 5(1): 6 doi: 10.29252/rmm.5.1.6
|
| 5 |
Arghavan Haj-sheykholeslami, Maryam Keshvari, Heidar Sharafi, Ali Pouryasin, Khalil Hemmati, Fatemeh Mohammadzadehparjikolaei. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients. World Journal of Gastroenterology 2015; 21(29): 8935-8942 doi: 10.3748/wjg.v21.i29.8935
|
| 6 |
Marcin P. Kaczor, Marta Seczyńska, Wojciech Szczeklik, Marek Sanak. IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency. Pharmacological Reports 2015; 67(2): 260 doi: 10.1016/j.pharep.2014.10.006
|
| 7 |
Abdelfattah M. Attallah, Dalia Omrang, Mohamed M. Omran, Mohamed A. Abdelrazek, Rania Zayed, Riham El Essawey, Sameh Saif, Azza Farid, Mohamed Hassany, Ayman Yosry, Ashraf Omar. Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C. Annals of Hepatology 2018; 17(4): 569 doi: 10.5604/01.3001.0012.0918
|
| 8 |
Moutaz Derbala, Nasser M. Rizk, Saad Al-Kaabi, Anil John, Manik Sharma, Nazeeh El-dweik, Rafie Yakoob, Fuad Pasic, Muneera Almohanadi, Khalid Alejji, Abdulatif Abdelmola, Mohamed Butt. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients. Virology 2013; 444(1-2): 292 doi: 10.1016/j.virol.2013.06.025
|
| 9 |
Yan Xu, Wenqian Qi, Xu Wang, Ping Zhao, Yonggui Zhang, Qian Zhang, Shaoyou Qin, Jiangbin Wang. Pegylated interferon α‐2a plus ribavirin for decompensated hepatitis C virus‐related cirrhosis: relationship between efficacy and cumulative dose. Liver International 2014; 34(10): 1522 doi: 10.1111/liv.12417
|
| 10 |
Daniele Blasquez Olmedo, Samária Ali Cader, Luís Cristóvão Porto. IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors. Journal of Medical Virology 2015; 87(10): 1702 doi: 10.1002/jmv.24227
|
| 11 |
E Cariani, L Roli, G Missale, E Villa, C Ferrari, T Trenti. Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis. The Pharmacogenomics Journal 2016; 16(1): 18 doi: 10.1038/tpj.2015.28
|
| 12 |
Mona Abdelmonem Esmail, Noha A. Hassuna, Khalda Sayed Amr, Eman Ramadan Ghazawy, Mohamed Abdel‐Hamid. Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients. Journal of Medical Virology 2016; 88(3): 481 doi: 10.1002/jmv.24354
|
| 13 |
M. A. Jiménez‐Sousa, J. Berenguer, A. Fernández‐Rodríguez, D. Micheloud, M. Guzmán‐Fulgencio, P. Miralles, D. Pineda‐Tenor, M. García–Álvarez, J. C. López, T. Aldámiz‐Echevarria, A. Carrero, S. Resino. IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV‐coinfected patients. Journal of Viral Hepatitis 2014; 21(3): 189 doi: 10.1111/jvh.12130
|
| 14 |
Alessandra Biasiolo, Andrea Martini, Patrizia Pontisso. New biomarkers for clinical management of hepatitis C virus infected patients. World Journal of Clinical Infectious Diseases 2015; 5(4): 59-66 doi: 10.5495/wjcid.v5.i4.59
|